Reduced incorporation of SARS-CoV spike protein into viral particles due to amino acid substitutions within the receptor binding domain

Japanese Journal of Infectious Diseases

Volumn 61, Issue 2, 2008, Pages 123-127

  Li, Shu Ming ^a   Li, Gui Mei ^a   Nakamura, Shota ^b   Ikuta, Kazuyoshi ^a,b   Nakaya, Takaaki ^a  

^a OSAKA UNIVERSITY   (Japan)

^b Thailand Japan Research Collaboration Center on Emerging and Re emerging Infections RCC ERI   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

M PROTEIN; STRUCTURAL PROTEIN; VIRUS SPIKE PROTEIN; VITRONECTIN;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING AFFINITY; CELL CLONE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; GENE MUTATION; GLYCOSYLATION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEIN CONFORMATION; PROTEIN DOMAIN; RECEPTOR BINDING; SARS CORONAVIRUS; SEQUENCE ANALYSIS; VIRION; VIRUS LIKE AGENT; VIRUS PARTICLE;

AMINO ACID SUBSTITUTION; ANIMALS; CERCOPITHECUS AETHIOPS; CLONE CELLS; MEMBRANE GLYCOPROTEINS; MUTATION; RECEPTORS, AMINO ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SARS VIRUS; VERO CELLS; VIRAL ENVELOPE PROTEINS; VIRAL MATRIX PROTEINS; VIRAL STRUCTURAL PROTEINS; VIRION;

EID: 43449093143     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Drosten, C., Gunther, S., Preiser, W., et al. (2003): Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med., 348, 1967-1976.
2. Rota, P.A., Oberste, M.S., Monroe, S.S., et al. (2003): Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science, 300, 1394-1399.
3. Marra, M.A., Jones, S.J., Astell, C.R., et al. (2003): The genome sequence of the SARS-associated coronavirus. Science, 300, 1399-1404.
4. Huang, Y., Yang, Z.Y., Kong, W.P., et al. (2004): Generation of synthetic severe acute respiratory syndrome coronavirus pseudoparticles: implications for assembly and vaccine production. J. Virol., 78, 12557-12565.
5. Hsieh, P.K., Chang, S.C., Huang, C.C., et al. (2005): Assembly of severe acute respiratory syndrome coronavirus RNA packaging signal into virus-like particles is nucleocapsid dependent. J. Virol., 79, 13848-13855.
6. Lin, S., Lee, C.K, Lee, S.Y., et al. (2005): Surface ultrastructure of SARS coronavirus revealed by atomic force microscopy. Cell Microbiol., 7, 1763-1770.
7. Li, W, Moore, M.J., Vasilieva, N., et al. (2003): Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature, 426, 450-454.
8. Li, F., Li, W., Farzan, M., et al. (2005): Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science, 309, 1864-1868.
9. He, Y., Lu, H., Siddiqui, P., et al. (2005): Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation dependent epitopes that induce highly potent neutralizing antibodies. J. Immunol., 174, 4908-4915.
10. Liu, L., Fang, Q., Deng, F., et al. (2007): Natural mutations in the receptor binding domain of spike glycoprotein determine the reactivity of cross-neutralization between palm civet coronavirus and severe acute respiratory syndrome coronavirus. J. Virol., 81, 4694-4700.
11. Yamate, M., Yamashita, M., Goto, T., et al. (2005): Establishment of Vero E6 cell clones persistently infected with severe acute respiratory syndrorite coronavirus. Microbes Infect., 7, 1530-1540.
12. Ivanov, K.A., Thiel, V., Dobbe, J.C., et al. (2004): Multiple enzymatic activities associated with severe acute respiratory syndrome coronavirus helicase. J. Virol., 78, 5619-5632.
13. Mizushima, S. and Nagata, S. (1990): pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res., 18, 5322.
14. Nakaya, T., Cros, J., Park, M.S., et al. (2001): Recombinant Newcastle disease virus as a vaccine vector. J. Virol., 75, 11868-11873.
15. Hwang, W.C., Lin, Y., Santelli, E., et al. (2006): Structural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R. J. Biol. Chem., 281, 34610-34616.
16. Prabakaran, P., Gan, J., Feng, Y, et al. (2006): Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody. J. Biol. Chem., 281, 15829-15836.
17. Voss, D., Kern, A., Traggiai, E., et al. (2006): Characterization of severe acute respiratory syndrome coronavirus membrane protein. FEBS Lett., 580, 968-973.
18. Oostra, M., de Haan, C.A., de Groot, R.J., et al. (2006): Glycosylation of the severe acute respiratory syndrome coronavirus triple-spanning membrane proteins 3a and M. J. Virol., 80, 2326-2336.
19. Simpson, D.A. and Lamb, R.A. (1991): Influènza virus ts61S hemagglutinin is significantly defective in polypeptide folding and intracellular transport at the permissive temperature. Virology, 185, 477-483.
20. Beniac, D.R., Andonov, A., Grudeski, E., et al. (2006): Architecture of the SARS coronavirus prefusion spike. Nat. Struct. Mol. Biol., 13, 751-752.